NUPREX-ER 500
Extended-Release Therapy for Epilepsy, Bipolar Disorder & Migraine
NUPREX-ER 500 is a scientifically formulated Divalproex Sodium 500 mg extended-release tablet developed by Felixn Pharmaceuticals.
It provides sustained control over epileptic seizures, stabilizes mood swings in bipolar disorder, and helps prevent migraine headaches by maintaining steady therapeutic levels throughout the day.With its once-daily extended-release profile, NUPREX-ER 500 ensures better compliance, improved tolerability, and long-term stability for neurological and psychiatric patients.
Key Benefits
✅ Effective in controlling generalized and partial seizures
✅ Prevents migraine recurrence and reduces attack frequency
✅ Helps manage manic episodes in bipolar disorder
✅ Provides 24-hour therapeutic coverage with a single dose
✅ Minimizes side effects through controlled drug release
Composition (Per Film-Coated Extended Release Tablet)
Each tablet contains:
- Divalproex Sodium I.P. – 500 mg
- Excipients: q.s.
- Colour: Titanium Dioxide I.P.
Indications
- Epilepsy / Seizure Disorders (Monotherapy or Adjunct Therapy)
- Bipolar Affective Disorder
- Migraine Prophylaxis
- Schizoaffective & Mood Stabilization Support
Dosage & Administration
Take one tablet daily, preferably after meals, or as directed by the physician.
Swallow whole with water — do not crush or chew.
Storage
Store in a cool, dry, and dark place below 30 °C.
Protect from light and moisture.
Keep out of reach of children.
Why Choose NUPREX-ER 500
- Manufactured in WHO-GMP & ISO-certified facilities
- Extended-release formulation for consistent plasma concentration
- Clinically tested for long-term seizure and mood control
- Ensures high patient adherence and reduced dosing frequency
- Recommended by neurologists and psychiatrists across India